Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.62 USD | -6.65% | -9.99% | 0.00% |
15/04 | Leerink Partners Starts LENZ Therapeutics With Outperform Rating, $32 Price Target | MT |
15/04 | William Blair Starts LENZ Therapeutics With Outperform Rating | MT |
Official Publications
No official publication found
- Stock Market
- Equities
- LENZ Stock
- News LENZ Therapeutics, Inc.
- Official Publications